Evonetix is in a very exciting phase, having recently opened our early access program. In 40 year career as an entrepreneur and venture capitalist, Hermann has helped start a number of technology companies, including Acorn Computers and its spin-out ARM, as well as Cambridge Silicon Radio and next-generation DNA sequencing technology company Solexa, which became the market leader and was later acquired by Illumina. Connected worker platform for frontline teams Our engineering team has decades of experience developing high integrity automated systems. The platform aims to deliver less expensive, higher quality, reduced turn-around-time oligonucleotide synthesis solutions. Malcolm joined Evonetix in June 2021 with over 20 years of experience. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Foresite Capital understands the unique business models in healthcare and works closely with the firms portfolio companies at all stages of their lifecycle. As well as leading on financial and related matters, Malcolm was the lead business partner to the sales and marketing, operations, and R&D functions. Matt joined Evonetix in 2019, as Head of Mechanical Engineering, after spending 12 years at Cambridge Consultants. Malcolm joined Evonetix in June 2021 with over 20 years of experience. He has experience working in a broad range of roles in start-ups, large corporations, government and consultancy. COMP. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. affect the user interaction and engagement with the company. Read more, Find prospects by the technologies they use. He focussed on Programme and Line Management in the UK before taking a secondment to the US to lead the expansion of the Boston site into Industrial and Consumer. By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners. 2023 EquityZen Inc. All rights reserved. Malcolm has worked globally (being based in the UK and Australia) and also across a range of industries. Evonetix is a Cambridge . Evonetixs proprietary synthesis process utilises a novel silicon chip, to control the synthesis of DNA at many thousands of independent thermally controlled reaction sites, or pixels, and their assembly into highly accurate long DNA on the chip surface through the companys patented Binary Assembly process. He was the first investor in DCVC-backed Totus Medicines, where he is a founding board member, and in Menten.AI. He was previously Chief Operations Officer at GreenPeak technologies B.V. (Qorvo Inc.) responsible for the mass production of Zigbee and Bluetooth devices servicing the TV/Set-top-box and IoT markets. Finance. +0.83%. However, researchers are constrained by the tools of the last generation of DNA synthesis technology. Matt holds a Masters degree in Mechanical Engineering from the University of Durham and is a Chartered Member of the Institution of Mechanical Engineers. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Blood stem cell company Garuda Therapeutics Inc. has raised $62 million in a series B round led by Northpond Ventures, OrbiMed Advisors, Cormorant Asset Management and Aisling Capital. Raquel Sanches-Kuiper was appointed Director of Biology of Evonetix in February 2017. Before these roles, Malcolm had over 15 years experience in professional services with PwC. KioBaser is building what it dubs "Nespresso machine of DNA synthesis". site you are consenting to these choices. Evonetix is ready to meet these challenges and open the door to the exciting next phase of our development., To apply to be included in the early access program, please visit: www.evonetix.com/access, View source version on businesswire.com: https://www.businesswire.com/news/home/20220816005493/en/, Lorna Cuddon Raquel holds a PhD in Molecular and Cell Biology from the Faculty of Medicine, University of Auvergne and a MSci in Biochemistry from the Faculty of Sciences, University of Lisbon. All trademarks are the property of Evonetix Ltd. or their respective owners. and Cambridge. By digitising processes and making knowledge more accessible to frontline workers, Zaptic is helping manufacturers significantly improve productivity, reduce waste and better meet customer demands. Bloomberg Daybreak Middle East. information on technology stack, industry listing, and other details. 2/7/2023. EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. and M.A in humanities fields completely unrelated to his investment interests. Molecular Assemblies develops an enzymatic DNA synthesis technology designed to power DNA-based products. UK-headquartered Zaptic, a frontline operations platform for manufacturing companies, has picked up $10 million in Series A funding. Cambridge, England, United Kingdom. EquityZen Securities LLC (EquityZen Securities) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm. The company was founded in 2015 and is based in Cambridge, U.K. Promote your product offering to tech buyers. Discover Evonetix alternatives or similar companies to benchmark and competitors' market analysis. At TED 2013, he delivered a Talk, Can technology solve our big problems? which has been seen 1.6 million times. The investment will fuel the development of Evonetix's semiconductor technology which enables accurate synthesis of thousands of sequences on a single chip andassembly of gene-length DNA in days rather than weeks. By combining DNA polymer synthesis technology, electronic nano-switches and semiconductor fabrication technologies, Iridia is developing a highly-parallel format to enable an array of nanomodules with the potential to store data at exceptionally high density. He works across a broad range of sectors from telecommunications to consumer products, focusing on the impact of digital platforms to enable new business models. Valuation. Also, check out the jobs and hiring category at Evonetix mentioned earlier on this page to identify PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Install and uncover Evonetixs employee details in less than 30 secs. Developer of instrumentation for gene synthesis analysis. He works with some of Cambridge Consultants largest clients, helping them maximise the value of innovation. Its unique no-code drag-and-drop functionality is claimed to ensure productivity, efficiency, and savings. Date. Get instant access to B2B contact data across the web, We use cookies to improve your browsing experience. He holds a PhD and MEng in Electronic Engineering, both from Loughborough University. To ensure the most secure and best overall experience on our website, we recommend the latest versions of. Interview with Dr Matthew Hayes, Chief Technology Officer, Team Talk Daniel Bygrave, Group Head of Software, Evonetix closes $24 million USD (20 million) financing. You can find their contact number, email address, and headquarters by She also acted as a Consultant for projects in collaboration with Genomics England, Technology Development and Applications, and Customer Support. On our trusted digital marketplace for private companies. Malcolm has worked globally (being based in the UK and Australia) and also across a range of industries. Dr. Vishal Gulati is one of the Europes leading digital healthcare investors. Jim assembles the people, ideas and money needed to launch products that save lives and improve healthcare. The shares are up nearly 300% since the start of 2020, while the . The platform has the potential to revolutionise the way this DNA is prepared and delivered to users in the rapidly growing field of synthetic biology, accelerating research in applications across pharma, biotech, food, agriculture, and data storage. The funds will be used by Zaptic to continue its growth, expand into new markets and new verticals. This year, DNA Day celebrates 70 years since James Watson and Francis Crick discovere t.co/7mzJmfskJg, Evonetix Ltd We have designed novelsemiconductor technologycapable of synthesising thousands of independent sequences across the surface of a single chip, re-engineered phosphoramidite chemistryto enable thermal control of the synthesis cycle, developednew ways to assemble DNAinto genes and established novel approaches toenzymatic DNAsynthesis. With this round, the total investment raised by Zaptic accounts for $16 million. Use Slintel to connect with top decision-makers at Evonetix Ltd. Prior to this, Mammen was an Executive Director and Regional Finance Director for the Asian business operations of Arthur D Little. Zaptic was founded by Richard Milnes in 2012 in the UK to address this issue faced by manufacturers. Trevor has a BSc in Computer Programming and Chemistry from Anglia Ruskin University. In 2012, he became a Fellow of the Royal Society in recognition of his contribution to the translation of science into business, in 2013 a Distinguished Fellow of BCS, the Chartered Institute for IT, and in 2015 an Honorary Knight Commander (KBE) for services to engineering and industry. About evonetix Stock. He has delivered commercial success in numerous leadership positions, including Vice President and General Manager and Vice President of Sales at Thermo Fisher Scientific, Vice President and Head of European Sales at Life Technologies and National Sales Manager at Qiagen. He joined Cambridge Consultants in 2001, and was responsible for the leadership of many of their largest and most technically challenging projects. Signet Jewelers doesn't get much attention on Wall Street, but the jewelry stock has crushed the market over the last three years. Determine how Evonetix's purchase behavior is going to change over the next few weeks. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Find useful insights on Evonetix's company details, tech stack, news alerts, competitors and more. Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle. Michael holds a PhD in Molecular Genetics and Protein Biochemistry from the Department of Biochemistry and Genetics at the University of Newcastle and has also completed numerous professional qualifications and training in marketing, management, and IP law. Colin brings over 20 years experience in commercial and business development roles. The Company has raised $30 million USD (23 million GBP) in this round, which was led by new investor Foresite Capital. For more than 50 years, Cambridge Consultants has led the way in innovative product development and not only been the development partner of choice to many of the worlds leading blue chips, but has also founded an array of ambitious start-up companies. Malcolm is responsible for a broad portfolio of financial, HR and other matters. Oversubscribed round led by Foresite Capital, Funding will enable development of DNA synthesis chip technology to commercial scale. Data Collective (DCVC) is a venture capital fund that backs entrepreneurs applying deep tech to transform giant industries. Evonetix is a growing biotechnology company which is set to revolutionisegene synthesis as needed to facilitate the View all Molecular Assemblies develops an enzymatic DNA synthesis technology designed to power DNA-based products. Trevor has a BSc in Computer Programming and Chemistry from Anglia Ruskin University. CB1 3LH. Farfetch Stock: Bull vs. Bear. August 16, 2022 at 05:13 AM EDT. Evonetix is a Cambridge-based company developing a radically different approach to gene synthesis. ", Jim Tananbaum Founder and Chief Executive Officer at Foresite Capital, commented: "We continue to be impressed by the Evonetix team and technology, and are excited to lead this round to accelerate their commercial strategy and make gene synthesis more accessible. Companies that are using technology to make farms more efficient. Before joining DCVC, he was a senior partner and senior advisor at Flagship Pioneering in Cambridge, MA, where he worked with the enterprises therapeutics and agriculture companies. You can read more about your cookie choices at our privacy policyhere. Let's dig . Raquel Sanches-Kuiper was appointed Director of Biology of Evonetix in February 2017. Duis aute irure dolor in reprehenderit in volup, To view Evonetixs complete valuation and funding history, request access, To view Evonetixs complete cap table history, request access, Youre viewing 5 of 29 competitors. He has written for a range of publications including a column for the New York Times and articles for many other newspapers and magazines like The Economist, The Financial Times, The Boston Globe and The Believer. Prior to that, Raquel was a post-doctoral researcher in the Department of Chemical Engineering and Biotechnology, University of Cambridge, in the area of cancer gene therapy. Java site you are consenting to these choices. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. Evonetix has 10 investors. Jason was CEO and editor in chief of MIT Technology Review and editor of Red Herring magazine, the bible of the dot.com boom. Among his operational responsibilities at DCVC, he helps portfolio companies tell their stories. Enzymatic DNA synthesis can write long, pure DNA, which is required to free the potential of synthetic biology applications, such as personalized medicines (including CAR-T cell therapies and CRISPR gene editing) and advanced agricultural and industrial products, through gene development and DNA-based data storage. She also acted as a Consultant for projects in collaboration with Genomics England, Technology Development and Applications, and Customer Support. Matt Hayes, Founder and Chief Technology Officer at Evonetix, said: We have been working on optimising the different elements of our technology ready to share DNA with researchers. In 2004, he was appointed a member of the Government Council for Science & Technology. Malcolm is a Fellow Chartered Accountant (FCA) of the Institute of Chartered Accountants in England and Wales and has an MA in Geography from the University of Cambridge. It leverages semiconductor-controlled synthesis on silicon which enables ultra-parallel DNA preparation, and moving capacity from remote service centers. These job postings data can help you identify how fast the company is growing Trevor was also responsible for the Industrialisation of new developments including Characterisation, Qualification and Production Test. 13 categories used by Evonetix mentioned earlier on this page. A major contributor to the global technology and growth agendas and an influential member of senior policy making bodies. Strong visitation to MGM's Las Vegas properties in Q4 2022 helped drive $2.3 billion in revenue, a remarkable 27% . Colin brings over 20 years experience in commercial and business development roles. Researchers are invited to apply to be included in the Companys early access program to receive some of the first DNA prepared using its technology and demonstrate the efficacy of Evonetix DNA in routine molecular biology workflows. As CEO of Evonetix, Colin will focus on building strategic partnerships and customer relationships, ahead of the commercial introduction of the Companys first benchtop DNA printer. Mammen graduated with a first class degree in Commerce from the University of Madras, India. Among his operational responsibilities at DCVC, he helps portfolio companies tell their stories. Jason was raised in Berkeley and on a farm on the North Coast of California, where his family raised game birds for restaurants in the Bay Area. Professor Sir David Klenerman is Professor of Biophysical Chemistry at the University of Cambridge, where he also earned his PhD. All rights reserved. Hermann holds an MA in Physics from Vienna University and a PhD in Physics from the University of Cambridge. Enzymatic DNA synthesis can write long, pure DNA, which is required to free the potential of synthetic biology applications, such as personalized medicines (including CAR-T cell therapies and CRISPR gene editing) and advanced agricultural and industrial products, through gene development and DNA-based data storage. Evonetixs DNA synthesis capability brings together patented semiconductor chip design and proprietary, thermally controlled synthesis chemistry, which will be integral to the Companys future gene synthesis platforms. Trevor was also responsible for the Industrialisation of new developments including Characterisation, Qualification and Production Test. Fulfilling the potential of synthetic biology demands new ways to achieve long, accurate DNA synthesis at unprecedented scale. Investors must be able to afford the loss of their entire investment. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists' ability to use synthetic biology on a scale not currently possible. Currently, leading manufacturers such as Carlsberg, Hovis, Berry Global and Celgard, use Zaptic as part of their transformation activities, digitising operations for frontline teams and accelerating operational excellence journeys. Building a platform capable of this requires highly parallel, distributed synthesis. We will respond in accordance with the CCPA. EVONETIX LTD (Evonetix), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the opening of its early access program for semiconductor synthesised DNA. This investment from Molten Ventures will allow us to scale our business to meet that demand and continue to invest deeply into creating an operational knowledge layer for workers, with operational data enabled by AI. Evonetixs proprietary process utilises a novel silicon chip to control the synthesis of DNA at many thousands of independent thermally controlled reaction sites, or pixels, on the chip surface. Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Before that, Trevor held roles as EDA Partner Manager at ARM Holdings, Director of Operations for Samsung Electronics and Director of Programme Management at CSR. The company aims to introduce a biochemical process for DNA and RNA synthesis based on the use of efficient enzymes. Draper Esprit was founded in 2006 with a mission to back Europes most ambitious entrepreneurs. Matthew Hayes is the Chief Technology Officer of Evonetix, and was a founder member of the team that created the company in 2015. DNA availability will no longer be a bottleneck, instead it will provide opportunities to design more ambitious experiments and deliver faster results. Evonetix's headquarters is located at 9A Coldhams Business Park, Norman Way, Cambridge. BSE - Scrip Code: 539437 Sub. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. This is a profile preview from the PitchBook Platform.
